Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$74.18 - $97.92 $259,259 - $342,230
-3,495 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$75.36 - $86.57 $256,977 - $295,203
-3,410 Reduced 49.38%
3,495 $264,000
Q2 2019

Aug 14, 2019

BUY
$83.92 - $108.88 $326,868 - $424,087
3,895 Added 129.4%
6,905 $590,000
Q1 2019

May 15, 2019

BUY
$85.97 - $108.09 $258,769 - $325,350
3,010 New
3,010 $325,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.